JCP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hara, A
Right arrow Articles by Okayasu, I
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hara, A
Right arrow Articles by Okayasu, I
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Brain Cancer
*Childhood Brain Tumors
J Clin Pathol 2001; 54:860-865
© 2001 Journal of Clinical Pathology

Loss of DCC expression in astrocytomas: relation to p53 abnormalities, cell kinetics, and survival

A Hara, M Saegusa, T Mikami, I Okayasu

Department of Pathology, Kitasato University School of Medicine, 1–15–1 Kitasato, Sagamihara, Kanagawa, 228–8555 Japan

Dr Hara mlc52923{at}nifty.com Aims—Although frequent reduction or loss of DCC (deleted in colorectal carcinomas) has been demonstrated in gliomas, the association with cell kinetics and survival is still unclear.

Methods—A total of 119 astrocytomas, comprising 39 grade IV, 36 grade III, and 44 low grade tumours, were immunohistochemically investigated, along with 26 normal adult brain samples and two fetal brains. The results were compared with p53 abnormalities, Ki-67 labelling index (LI), mitotic index (MI), apoptotic index (AI), and survival.

Results—In normal adult and fetal brain tissues, DCC expression was detected in mature and terminally differentiated neuronal cells but not glial elements. In astrocytomas, whereas DCC expression was still clearly shown with low grade malignancy, DCC scores were significantly decreased in high histological grade malignancy, along with an increase in cell kinetics determined by AI, MI, and Ki-67 LI values. In addition, p53 LI values were significantly increased, although a direct link between DCC scores and p53 LI values was not evident. Univariate analysis revealed that high DCC scores and low p53 LI values were closely related to a favourable outcome for astrocytoma, although only the AI was an independent prognostic factor.

Conclusions—The loss of DCC expression may be closely related to changes in cell kinetics and tumour phenotype in astrocytomas, independent of p53 abnormalities.

Key Words: astrocytoma • deleted in colorectal carcinoma gene • p53 • cell kinetics




This article has been cited by other articles:


Home page
J. Clin. Pathol.Home page
A Hara, M Saegusa, M Ichinoe, and I Okayasu
Diagnostic and prognostic significance of cyclin A expression in low-grade astrocytomas: comparison with astrogliosis and high-grade tumours
J. Clin. Pathol., March 1, 2008; 61(3): 287 - 292.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
P. Mehlen and E. R. Fearon
Role of the Dependence Receptor DCC in Colorectal Cancer Pathogenesis
J. Clin. Oncol., August 15, 2004; 22(16): 3420 - 3428.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Journal of Clinical Pathology Molecular Pathology
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2001 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.